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Decidualization is a process that involves phenotypic and functional changes of
endometrial stromal cells to sustain endometrial receptivity and the participation of
immunoregulatory factors to maintain immune homeostasis. In this context, tolerogenic
dendritic cells (DCs) can induce regulatory T cells, which are essential to manage
the pro- to anti-inflammatory transition during embryo implantation. Recently, Myeloid
Regulatory Cells (MRCs) were proposed as immunosuppressants and tolerance-inducer
cells, including the DC-10 subset. This novel and distinctive subset has the ability
to produce IL-10 and to induce type 1 regulatory T cells (Tr1) through an HLA-G
pathway. Here we focus on the impact of the decidualization process in conditioning
peripheral monocytes to MRCs and the DC-10 subset, and their ability to induce
regulatory T cells. An in vitro model of decidualization with the human endometrial
stromal cell line (HESC), decidualized by medroxyprogesterone and dibutyryl-cAMP
was used. Monocytes isolated from peripheral blood mononuclear cells from healthy
women were cultured with rhGM-CSF + rhIL-4 and then, the effect of conditioned
media from decidualized (Dec-CM) and non-decidualized cells (Non-dec-CM) was
tested on monocyte cultures. We found that Dec-CM inhibited the differentiation to
the CD1a+CD14− immature DC profile in a concentration-dependent manner. Dec-CM
also significantly increased the frequency of CD83+CD86low and HLA-DR+ cells in the
monocyte-derived culture. These markers, associated with the increased production of
IL-10, are consistent with a MRCs tolerogenic profile. Interestingly, Dec-CM treatment
displayed a higher expression of the characteristic markers of the tolerogenic DC-10
subset, HLA-G and ILT2/CD85j; while this modulation was not observed in cultures
treated with Non-dec-CM. Moreover, when monocyte cultures with Dec-CM were
challenged with LPS, they sustained a higher IL-10 production and prevented the
increase of CD83, CD86, IL-12p70, and TNF-α expression. Finally, the DC-10 subset
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was able to induce a CD4+HLA-G+ regulatory T cells subset. These results suggest
that the decidualization process might induce different subsets of MRCs, like DC-10,
able to induce regulatory T cells as a novel CD4+HLA-G+ subset which might play an
immunoregulatory role in embryo implantation.
Keywords: decidualization, DC-10, dendritic cells, immunomodulation, HLA-G, myeloid regulatory cells
INTRODUCTION
The maternal immune system was subjected to opposing
selective pressures over millions of years of evolution: on the
one hand it recognizes microbial pathogens and responds
to eliminate them, whereas on the other hand, it accepts
semi-allogeneic fetuses without ignoring its existence. Hence,
the embryo has an “immunoprivileged status” that allows
the establishment of early pregnancy by instructing immune
tolerance induction in the maternal immune system. Therefore,
the feto-maternal interface is characterized by dynamism:
the microenvironment changes as pregnancy progresses
accompanied by immunological phases with different profiles
(1). The changes of the maternal immune profile are strictly
controlled by complex regulatory mechanisms at decidualization,
implantation, and placentation.
Particularly, the decidualization program involves phenotypic
and functional changes of endometrial stromal cells and not
only sustains the endometrial receptivity, but also allows the
secretion of immunoregulatory factors which may condition
maternal leukocytes to a regulatory profile (2). This process is
unique and characteristic of endometrium and, in humans, it
is activated independently of the presence of the blastocyst (2,
3). In this context, even though myeloid dendritic cells (DCs)
are only 1–2% of decidual leukocytes, they initiate the adaptive
immunity and, therefore, they are crucial for the establishment
of immunological tolerance (1, 4). DCs in human decidua
represent a complex population and their number fluctuates
through different phases of the menstrual cycle and during
pregnancy (5–8). Interestingly, in the last few years, Myeloid
Regulatory Cells (MRCs) have been proposed as immune-
suppressors and tolerance-inducers including the DC-10 (9,
10). This novel subset represents tolerogenic DCs (Tol-DCs)
which notably spontaneously secrete large amounts of IL-10
and express different tolerogenic markers such as membrane-
HLA-G and its receptors immunoglobulin-like transcript (ILT)
2, ILT-3, and ILT-4 (11). In fact, DC-10 are able to induce T
cells anergy and type 1 regulatory T cells (Tr1) through the IL-
10-dependent ILT4/HLA-G pathway in vitro (11). Remarkably,
even though a single stimulation of allogeneic naïve T cells
with DC-10 is sufficient to generate allo-specific Tr1 cells, the
chronicity of allogeneic stimulation reinforces Tr1 induction
(12). Previous reports indicate a higher percentage of DC-10
into the human decidua compared to peripheral blood during
the first trimester of pregnancy; but, it is still unknown if these
cells are recruited to the decidua or induced in situ (6). Tol-
DCs also have the ability to induce regulatory T cells (Tregs,
CD4+FOXP3+), a critical role in pregnancy that was proven
using several in vivo and in vitro approaches in murine models
as well as in humans (13–17). Recently, T cell subsets, which do
not express FOXP3, with immunosuppressive ability based on
the increase in HLA-G expression and IL-10 production were
reported (8). The expression of HLA-G on T cells could be
induced by DCs (6, 18, 19). The frequency of CD4+HLA-G+ cells
in peripheral blood increases in healthy pregnant women, being
even more pronounced within the decidua (6, 18); however, it
is still unclear whether the decidualization program modulates
their induction.
Since T cells and DCs are critical to sustain homeostasis in
pregnancy, here we focused on the impact of the decidualization
process in conditioning peripheral monocytes to MRCs and,
particularly to the DC-10 subset. Finally, we investigated the
ability of DC-10 to induce different regulatory T cell subsets.
MATERIALS AND METHODS
Reagents
Endotoxin-free reagents and plastic materials were used in
all experiments. RPMI-1640, phosphate-buffered saline (PBS),
Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine
serum (FBS), and penicillin/streptomycin were purchased from
Gibco (Invitrogen, Argentina). Twenty-four-well flat bottom
polystyrene plates were purchased from Jet-biofil (AP Biotech,
Buenos Aires, Argentina) while 96-well U-bottom plates and
half-area 96-well ELISA were obtained from Greiner Bio
One (GBO, Buenos Aires, Argentina). Ficoll-Paque PLUS
and Percoll were obtained from GE Healthcare Life Sciences
(Embiotec, Buenos Aires, Argentina). Recombinant human IL-
4 and recombinant human granulocyte-macrophage colony-
stimulating factor (GM-CSF) were obtained from Miltenyi Biotec
(Lab Systems, Buenos Aires, Argentina). Lipopolysaccharide
(LPS) from Escherichia coli was purchased from Sigma-Aldrich
(Merck, Argentina).
Blood Samples
Buffy coats were obtained from fertile female volunteers,
defined as women who had two or more previous normal
pregnancies without any miscarriage in their clinical history,
were non-smokers, and who were not under pharmacological
treatment for at least 10 days before the day of sampling. The
Investigation and Ethics Committees of ‘Academia Nacional
de Medicina’ from CABA, Argentina have approved this
study. All research was performed in accordance with relevant
guidelines and regulations, and written informed consent for
the collection of samples and subsequent analyses was obtained
from all blood donors recruited by “Fundación Hemocentro
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Buenos Aires,” CABA, Argentina in accordance with the
Declaration of Helsinki.
Human Endometrial Stromal Cell Line
Culture
The human endometrial stromal cell (HESC) line was
maintained in DMEM-F12 supplemented with 10% FBS,
50 U/ml penicillin, 50 µg/ml streptomycin, and 2 mM
glutamine (20, 21) (complete medium). This cell line was
kindly provided by Dr. Gil Mor of Medical School, Yale
University, United States.
Decidualization: HESC cells were cultured in 24-well plates
until they reached 70% confluence with complete medium. Then,
they were treated with medroxyprogesterone (MPA) (10−7M)
and dibutyryl cAMP (db-cAMP) (2.5 × 10−3M) for 8 days
(Dec), changing half of the culture media and renewing the
stimuli every 48 h. The decidualization process was confirmed
by the evaluation of decidual markers and cell viability, as
previously described (22). Non-decidualized (Non-dec) cells
were cultured simultaneously in similar conditions in absence of
decidualization stimuli.
After 8 days of culture, Non-dec and Dec-HESC cells
were washed three times and cultured in RPMI 1640
medium supplemented with 10% of heat inactivated FBS,
50 U/ml penicillin, and 50 µg/ml streptomycin (DC complete
medium) for an additional 48 h and Conditioned Media (CM)
were collected.
Dendritic Cells Differentiation
Peripheral blood mononuclear cells (PBMC) were isolated from
buffy coats by Ficoll-Paque PLUS density gradient centrifugation
(1.077 g/mL). Monocytes were isolated by centrifugation on a
discontinuous Percoll gradient with modifications of a previously
described method (23, 24). Briefly, PBMC were suspended in
Ca2+, Mg2+-free Tyrode’s solution supplemented with 0.2%
EDTA and incubated for 45 min at 37◦C. During this incubation,
the osmolarity of the medium was gradually increased from
290 to 360 osmol/l by addition of NaCl. Two different
Percoll fractions were layered in polypropylene tubes: 50%
at the bottom followed by 40%. PBMC (40 × 106/ml) were
layered at the top and they were centrifuged at 620 g for
50 min at 4◦C. Monocytes were recovered at the interface,
washed, and the purity and viability were checked by flow
cytometry analysis and trypan blue exclusion, respectively. The
purity and the viability accepted in all cases were >85% and
>95%, respectively.
To obtain immature DC (Media-treated cells), monocytes
(1 × 106/ml) were cultured in DC complete medium with
30 ng/ml IL-4 and 30 ng/ml GM-CSF in 96-well U-bottom
plates for at least 5 days. The expression of CD1a/CD14 was
measured to confirm the differentiation to immature DC as
previously described (25). In parallel, monocytes were also
cultured in DC complete medium with IL-4 + GM-CSF in
presence of HESC-CM (Non-dec-CM or Dec-CM). On the
last day, cell supernatants were collected, and the phenotype
was analyzed by flow cytometry. In some cases, on day 5,
the cells were treated with LPS 0.2 µg/ml for 18 h if was
required for the assays.
All experiments were performed independently using different
donor monocytes (N is indicated in the legend of each figure).
Endocytosis Assay of FITC-OVA
At day 6 of differentiation, monocyte-derived cells were
suspended at 2 × 106 cells/ml in fresh medium. FITC-
Ovalbumin (FITC-OVA) was added at a final concentration of
100 µg/ml and cells were incubated for 25 min at 37◦C. In
parallel, a control was incubated on ice to determine unspecific
binding. Cells were washed two times with ice-cold 2% FBS/PBS
and fixed with 1% paraformaldehyde. The FITC-OVA uptake
was then evaluated by flow cytometry as we have previously
described (26).
Mixed Lymphocyte Reaction
Monocytes (5 × 104 cells/100 µl) were differentiated in
presence or absence of 1:2 dilution HESC-CM for 6 days. The
obtained monocyte-derived cells were then suspended in DC
complete medium with 2.5 × 105 freshly isolated allogeneic
lymphocytes (DC/lymphocyte ratio = 1/5) and cultured for
5 days more as we have previously described (25). The
monocytes and lymphocytes used for mixed lymphocyte reaction
(MLR) were isolated by centrifugation on a discontinuous
Percoll gradient described above, reaching a purity >90 and
>95%, respectively. At the last day of MLR, we evaluated the
expression of different markers on T cells by flow cytometry
and their cytokine production profile was evaluated in cell
supernatants by ELISA.
Flow Cytometry
Cells were washed with PBS supplemented with 2% FBS/PBS and
FITC-, APC- and PE-conjugated mAbs directed to CD1a, CD14,
CD86, HLA-DR, CD83, CD4, CD25 (BD Biosciences), ILT-
2/CD85j, and HLA-G (BioLegend, San Diego, CA, United States)
or the corresponding isotype controls were added at saturating
concentrations for 30 min at 4◦C. Then, two additional washes
were performed, and cells were fixed with 1% paraformaldehyde.
Stained cells were acquired using an FACS Calibur and
FACSAria II cytometers and results were analyzed using
FlowJo 7.6 Software.
Measurement of Cytokines by ELISA
Cytokines were evaluated in cell supernatants using commercial
kits: IL-10, IL-12p70, TNF-α, and IFN-γ (BD Biosciences),
according to the manufacturer’s recommendations.
Statistical Analysis
GraphPad Prism (GraphPad Software Inc., San Diego, CA,
United States) was used to perform all statistical tests.
Statistical significance was determined using the non-
parametric Friedman test with Dunn’s multiple comparisons
post-test. Statistical significance was defined as p < 0.05
and exact p-values and comparisons were indicated in
each graph.
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RESULTS
Decidualized Cells Inhibit Monocyte
Differentiation to CD1a+CD14−
Immature DC Profile in a
Concentration-Dependent Manner
Considering that endometrial stromal cells change their
secretome during the decidualization process, including
the production of immunoregulators, we evaluated the
influence of conditioned media (CM) of decidualized (Dec)
and non-decidualized (Non-dec) HESC cells on immature
DC differentiation. Monocytes were cultured to differentiate
into immature DC with GM-CSF + IL-4 in absence (Media)
or presence of different dilutions of Non-dec or Dec-CM for
5 days. As Figure 1A shows, Dec-CM inhibited monocyte
differentiation to CD1a+CD14− immature DC profile in a
concentration-dependent manner. On the other hand, this effect
was also accompanied by a persistence of CD1a−CD14+ cells
(Figure 1B). Figure 1C shows representative dotplots of the
immunostaining of DC differentiated in the absence or presence
of CM from endometrial cells before and after decidualization.
Altogether, the present results suggest that CM from
endometrial cells, after decidualization, interfere with DC
differentiation while it increases the frequency of CD1a−CD14+.
Decidualized Cells Induce a Myeloid
Regulatory Cells-Profile on
Monocyte-Derived Cultures
To characterize the phenotype of monocyte-derived cells
acquired after the treatment with Dec-CM, we tested
activation/maturation markers as HLA-DR, CD86, and
CD83 expressions. We observed that monocyte-derived cells
cultured with Dec-CM showed a higher expression of HLA-DR
(Figures 2A,B,D) compared with culture medium. In fact, it
also increased the expression of the maturation marker CD83
(Figures 2C,E). Surprisingly, Dec-CM increased the frequency
of CD83+CD86low while it diminished the frequency of the
CD86high population (Figures 2C,E). In line with its mature
FIGURE 1 | Decidualized cells inhibit monocyte differentiation to immature DC in a concentration-dependent manner. Monocytes were cultured to differentiate to
immature DC in absence (Media) or presence of different dilutions of Non-dec or Dec-CM for 5 days. Then, the CD1a/CD14 expression was evaluated by flow
cytometry. (A,B) Mean ± SEM of positive cells from at least eight experiments are shown. Dotted lines represent the mean of positive cells of Media-treated culture.
(C) Representative experiment of 1:2 dilution of CM is shown. The statistical test used is the Friedman test with Dunn’s multiple comparisons post-test. p-values and
comparisons were indicated in graph; p-values without lines indicate comparisons with dotted lines (Media).
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phenotype, monocyte-derived cells differentiated with Dec-CM
displayed significantly lower endocytic ability in an ovalbumin
(OVA)-FITC uptake assay (Figures 2F,G).
When the cytokine secretion profile was evaluated, we
observed that monocyte-derived cells differentiated in the
presence of CM from HESC cells, either decidualized or not,
secreted significantly higher levels of IL-10 compared to the
culture medium, while IL-12 secretion was not modulated
(Figures 3A,B). Notably, Dec-CM did not induce the production
of TNF-α by monocyte-derived cells as Non-dec-CM did,
highlighting the ability of Dec-CM to induce a different cytokine
profile in these cultures (Figure 3C).
Altogether, the present results suggest that endometrial
stromal cells, after decidualization, might induce an
immunosuppressive regulatory phenotype on monocytes
like the MRCs.
Decidualized Cells Prevent LPS-Induced
Maturation of Monocyte-Derived Cells
Next, to confirm the maturation state and the activation of
monocyte-derived cells differentiated in the presence of Dec-
CM, we challenged them with LPS for 16 h and cytokine profile
production and the activation/maturation marker’s expression
were assessed. As shown in Figure 3D, upon activation with
LPS, Dec-CM cultures sustained higher IL-10 production while
it prevented the increase of IL-12p70 and TNF-α secretion
compared to culture medium-treated cells (Figures 3E,F).
Moreover, in the presence of Dec-CM, significant increase of
IL-10 and decrease of TNF-α expression in comparison with
Non-dec-CM were observed, highlighting the effect of the
decidualization treatment. On the other hand, the expression
of activation/maturation markers in monocyte-derived cells,
cultured or not, with HESC-CM and challenged with LPS
was determined. Dec-CM treatment significantly prevented the
increase in the frequency of HLA-DRhigh, CD83+CD86+, and
CD86high subsets observed with LPS treatment (Figures 4A–E).
Notably, a tendency to prevent the increase in the frequency
of these subsets was also observed in Non-dec-CM cultures
compared to the culture medium, reaching significance in the
CD86high subset (Figure 4E).
The present results indicate that, once decidualized,
endometrial stromal cells might not only induce a phenotype
like MRCs on monocyte-derived cells but also condition their
functional status.
Decidualized Cells Favor a Higher
Expression of the Characteristic
Tolerogenic DC-10 Subset Markers on
Myeloid Cells, HLA-G and ILT-2/CD85j
Based on the results shown above and considering that DC-
10 spontaneously produce high amounts of IL-10 and increase
tolerogenic markers, we next evaluated the ability of Dec-CM to
induce tolerogenic markers on monocyte-derived cells. HLA-G
expression was significantly increased in Dec-CM-treated cells
compared to Non-dec-CM-treated cells. The increase of HLA-G
expression was observed in both frequency and MFI parameters
(Figures 5A,B,D). As expected, the expression of the HLA-
G receptor, ILT-2/CD85j, was increased on monocyte-derived
cells cultured in the presence of Dec-CM, compared to culture
medium-treated cells (Figures 5C,E) suggesting that endometrial
stromal cells might induce differentiation into the DC-10 subset
compatible with a tolerogenic microenvironment only after
decidualization. Interestingly, both DC-10-tolerogenic markers
were not increased in those cultures treated with Non-dec-CM,
highlighting the specificity of the decidualization process.
Decidualized Cells Condition
Monocyte-Derived Cells to an
Immunosuppressive and Tolerogenic
Profile After Allogeneic Stimulation:
CD4+HLA-G+ T Cells Induction
As described above, the DC-10 subset induced regulatory T cells
with suppressor function through the IL-10-dependent HLA-G
pathway. Taking into account the higher expression of HLA-
G and ILT-2 markers in Dec-CM cultures, we evaluated the
ability of these conditioned monocyte-derived cells to induce a
tolerogenic and suppressor response after allogeneic stimulation
in the mixed lymphocyte reaction (MLR). Hence, monocyte-
derived cells that had been differentiated in the presence or
absence of HESC-CM for 6 days were cultured with allogeneic
lymphocytes for 5 days more. On the last day of MLR,
we evaluated the expression of different markers on T cells
by flow cytometry and their cytokine production profile by
ELISA. An anti-inflammatory microenvironment characterized
by higher IL-10 and lower IFN-γ production was observed in
cultures treated with either HESC-CM, compared to medium
cultures (Figures 6A,B). These results suggest the induction
of suppressor and regulatory profiles on T cells in both MLR
cultures, although the IL-10:IFN-γ ratio was significantly higher
only in Dec-CM cultures (Figure 6C). In parallel, we evaluated
the expression of the activation marker CD25, on allogeneic
lymphocytes in these MLR cultures. We observed a significant
decrease in the frequency of CD4+CD25+ cells in Dec-CM-
cultures (Figures 7A,B), suggesting that monocyte-derived cells
differentiated with CM of decidualized cells inhibited allogeneic
CD4+ T cells activation. Finally, a significant increase in the
frequency of CD4+HLA-G+ cells was observed in Dec-CM-
cultures compared with Non-dec-CM-cultures, indicating a
specific effect of decidualization (Figures 7C,D).
The present results suggest that HESC cells condition
the monocyte-derived cells to an immunosuppressive
profile accompanied by a decrease in the frequency of allo-
activated T cells. Particularly Dec-CM-treated cells displayed
a higher IL-10:IFN-γ ratio production and an increase in the
CD4+HLAG+ T cells subset.
DISCUSSION
For many years, it was assumed that decidualized cells
had a structural, passive role during embryo implantation,
only associated with morphological changes of stromal cells.
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FIGURE 2 | Decidualized cells induce an MRC-profile on monocyte-derived cultures with higher frequency of CD83+CD86low and HLA-DRhigh cells. Monocytes
were cultured to differentiate to immature DC in absence (Media) or presence of 1:2 dilution of Non-dec or Dec-CM for 5 days. (A–E) After differentiation, the
expression of HLA-DR, CD86, and CD83 was measured by flow cytometry. Representative experiments are shown in panels (A–C) and the mean ± SEM of positive
cells or MFI from five to eight experiments is shown in panels (D,E). (F,G) On day 6, cells were washed and stimulated with OVA-FITC in fresh medium for 25 min at
37◦C and the endocytic ability was evaluated by flow cytometry. Cells incubated with FITC-OVA in ice were used as negative control. The mean ± SEM of MFI from
seven experiments is shown in panel (F) and the representative experiment is shown in panel (G). The statistical test used is the Friedman test with Dunn’s multiple
comparisons post-test. Exact p-values and comparisons are indicated in the graph.
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FIGURE 3 | Decidualized cells induce IL-10++ secretion on monocyte-derived cells and prevent the increase of IL-12p70 and TNF-α secretion upon maturation with
LPS. Monocytes were cultured to differentiate to immature DC in absence (Media) or presence of 1:2 dilution of Non-dec or Dec-CM for 5 days and then, cells were
stimulated (D–F) or not (A–C) with LPS 0.2 µg/ml for 18 h. The secretion of IL-10, IL-12 and TNF-α was evaluated by ELISA. Bars represent the mean ± SEM of
four to eight experiments. Dotted lines represent the mean of Media-treatment without LPS. The statistical test used is the Friedman test with Dunn’s multiple
comparisons post-test. Exact p-values and comparisons are indicated in the graph.
Nowadays, evidence indicates that the decidualization program
conditions the endometrium for receptivity as well as for local
leukocyte profiling (1, 27, 28). In fact, defects in decidualization
could condition future pregnancies as observed in women with
severe preeclampsia (29).
Here, we provide new experimental evidence on the
decidualization program as a conditioning factor for the
differentiation of maternal monocytes to a unique and
special subset of Tol-DC, the DC-10, thus contributing to
the establishment of tolerogenic and immune suppressor milieu
by regulatory T cells induction. Our conclusions are based
on several observations. First, Dec-CM inhibited monocyte
differentiation to a classical CD1a+CD14− immature DC profile
in a concentration-dependent manner. Instead, CM induced a
particular MRC-profile with a mature state and a higher IL-10
production on monocyte-derived cells. Moreover, Dec-CM
prevented the increase of co-stimulatory molecules expression
and pro-inflammatory cytokines production induced by LPS-
stimulation. Finally, monocyte-derived cells differentiated
in the presence of Dec-CM, expressed a higher level of
DC-10-tolerogenic markers, HLA-G and ILT-2/CD85j, resulting
in an immune suppressor and tolerogenic response with a higher
IL-10:IFN-γ ratio and an increased frequency of regulatory
CD4+HLAG+ T cells.
Stromal cells are non-hematopoietic cells; however, they
have the ability to mediate anti-inflammatory effects through
targeting natural killer cells, monocyte/macrophages, DCs and
inducing Tregs (30–32). The mechanisms involve cell contact
and the production of soluble factors, including Indoleamine
2,3-dioxygenase (IDO), TGF-β, IL-10, PGE2, and nitric oxide
among other chemokines and cytokines (30–32). In this
sense, the endometrium suffers regular cycles of menstruation,
repair, proliferation, and differentiation under hormonal control.
Endometrial leukocytes and derived-mediators play important
roles not only in the decidualization and embryo implantation
but also as local regulators in menstrual tissue breakdown
and endometrial repair (33). It was reported that during
the pre-decidualized phase the endometrium switches from a
pro-inflammatory to an anti-inflammatory microenvironment
(33). In this line, we observed that monocyte-derived cells
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FIGURE 4 | Decidualized cells prevent LPS-induced maturation of monocyte-derived cells. Monocytes were cultured to differentiate to immature DC in absence
(Media) or presence of 1:2 dilution of Non-dec or Dec-CM for 5 days and then, cells were stimulated with LPS 0.2 µg/ml for 18 h. The expression of HLA-DR (A,C),
CD83, and CD86 (B,D,E) was evaluated by flow cytometry. Representative experiments are shown in panels (A,B) and the mean ± SEM of positive cells from five to
seven experiments is shown in panels (C–E). Dotted lines represent the mean of positive cells of Media-treatment without LPS. The statistical test used is the
Friedman test with Dunn’s multiple comparisons post-test. Exact p-values and comparisons are indicated in the graph.
differentiated in presence of Non-dec-CM also acquired some
features similar to those observed in Dec-CM cultures such
as HLA-DR expression, IL-12 production, and CD4+CD25+
frequency with higher IL-10 and lower IFN-γ production
after MLR. Therefore, Non-dec-CM might induce an anti-
inflammatory profile on DC, though it is not as marked as the one
induced by Dec-CM. Thus, we might infer that DC would begin
to acquire characteristics associated with an anti-inflammatory
profile during the pre-decidualization phase, reaching a more
robust tolerogenic profile during the decidualization process.
Here, we demonstrated that monocyte-derived cells
differentiated in the presence of Dec-CM exhibit a particular
CD83+CD86low mature status with high expression of HLA-
DR and spontaneous production of high amounts of IL-10.
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FIGURE 5 | Decidualized cells favor a higher expression of the characteristic tolerogenic DC-10 subset markers on myeloid cells, HLA-G and ILT-2/CD85j.
Monocytes were cultured to differentiate to immature DC in absence (Media) or presence of 1:2 dilution of Non-dec or Dec-CM for 5 days and the expression of
HLA-G and ILT2/CD85j was evaluated by flow cytometry. Representative experiments are shown in panels (A–C) and the mean ± SEM of positive cells or MFI from
six to ten experiments is shown in panels (D,E). The statistical test used is the Friedman test with Dunn’s multiple comparisons post-test. Exact p-values and
comparisons are indicated in the graph.
FIGURE 6 | Decidualized cells condition monocyte-derived cells to an immunosuppressive profile after allogeneic stimulation. Monocyte-derived cells (5 × 104
cells/100 µl) that had been differentiated in presence or absence of 1:2 dilution of Non-Dec or Dec-CM for 6 days were suspended in DC complete medium and
co-cultured with allogeneic lymphocytes for 5 days more (DC/lymphocyte ratio = 1/5). On the last day of MLR, the IL-10 and IFN-γ secretion was evaluated by
ELISA. Bars represent the mean ± SEM of six experiments (A,B) and scatter dot-plots represent the mean ± SEM of the IL-10:IFN-γ ratio production (C). The
statistical test used is the Friedman test with Dunn’s multiple comparisons post-test. Exact p-values and comparisons are indicated in the graph.
Accordingly, in the last few years, Gregori et al. characterized a
subset of Tol-DC, the DC-10 subset, which can be differentiated
in vitro from monocytes with GM-CSF + IL-4 and IL-10
(11). DC-10 are CD1a−CD14+ and display a mature myeloid
phenotype (CD83+CD86+ and HLA-DRhigh) even in the absence
of activation stimuli. Moreover, they secrete spontaneously high
levels of IL-10 and express the tolerogenic markers HLA-G,
ILT-2, ILT-3, and ILT-4. This phenotype turns them into
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FIGURE 7 | Decidualized cells condition monocyte-derived cells to an immunosuppressive and tolerogenic profile with induction of CD4+HLA-G+ T cells after
allogeneic stimulation. Monocyte-derived cells (5 × 104 cells/100 µl) that had been differentiated in presence or absence of 1:2 dilution of Non-Dec or Dec-CM for
6 days were suspended in DC complete medium and co-cultured with allogeneic lymphocytes for 5 days more (DC/lymphocyte ratio = 1/5). On the last day of MLR,
the expression of CD4, CD25, and HLA-G was evaluated by flow cytometry, gating on lymphocytes. Representative dot plots are shown in panels (A,C). Bars
represent the mean ± SEM of positive cells from four experiments (B,D). The statistical test used is the Friedman test with Dunn’s multiple comparisons post-test.
Exact p-values and comparisons are indicated in the graph.
potent inducers of Tr1 in vitro through the IL-10-dependent
ILT-4/HLA-G pathway (11).
Although DC-10 share some similarities with other
tolerogenic antigen-presenting cells, they represent a unique
subset of Tol-DC that is phenotypically and functionally stable
(34). Upon activation, DC-10 maintain their phenotype and their
cytokine secretion profile with high IL-10 and low IL-12/TNF-α
production. In accordance, here we showed that Dec-CM
prevented the maturation of DC by LPS, inhibited IL-12 and
TNF-α production, and increased even more the secretion of
IL-10. The presence of DC-10 was recently reported in first
trimester decidua and peripheral blood (6). However, it is still
unclear if the increased frequency of DC-10 observed in the
decidua is due to: (a) a higher recruitment from peripheral
blood, (b) an increased conversion of resident decidual DCs into
DC-10, or (c) if the decidual microenvironment promotes the de
novo induction of DC-10 from monocytes recruited. Regarding
the aforementioned frequency and based on the results presented
here, we propose that the novo induction of DC-10 could be
occurring within human decidua and independently of the
blastocyst presence.
The frequency of DCs in human endometrium reaches its
highest level during the implantation window (35) and it is
associated to their ability to release soluble factors that improve
the endometrial receptivity (36, 37). In this context, previous
work performed in mice provided strong evidence of the
indispensability of DCs in decidua formation and implantation
(38, 39). IL-10 promotes the expression of several tolerogenic
molecules in human DCs and in other antigen-presenting cells,
including IL-10 itself, hemo-oxygenase (HO-1), ILT-3, and ILT-
4 as well as another important mediator of immune tolerance in
pregnancy, the HLA-G. This atypical MHC class I molecule, is
one of the ILT-2/ILT-4 ligands with potent immunosuppressive
properties (40).
In accordance with these observations, in our in vitro model
of immune-decidual interaction, we demonstrated that Dec-CM
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was able to induce HLA-G and increased ILT-2 expression
on monocyte-derived cells. Interestingly, these DC-10-
tolerogenic markers were not increased at all by Non-dec-
CM treatment. It has been reported that the continuous
ligation of ILT-2 on immature DC during differentiation
maintains CD14 expression, inhibits the acquisition of
CD1a expression and prevents the activation with LPS
(41, 42). In fact, ligation through ILT-2 may preferentially
induce and/or interact with Tregs that maintain T-cell
unresponsiveness (42). Considering that the decidualization
process increased IL-10 production by stromal cells (43),
which induces the expression of IL-10, HLA-G and ILT-
4 on DC-10 (11), and that HLA-G itself is able to
up-regulate the expression of ILT-2 and ILT-4 (44), we
suggest that Dec-CM induces a positive regulatory loop
between IL-10 and these tolerogenic markers in monocyte-
derived cultures.
In vitro experiments have demonstrated that DCs isolated
from the decidua (45) are poor stimulators of allogeneic
lymphocytes. Accordingly, here we showed for the first time
that allogeneic lymphocytes co-cultured with monocytes-derived
cells conditioned by Dec-CM treatment are hypo-responsive
with significantly decreased CD25+ expression, particularly
on the CD4+ subset. Indeed, a significantly higher IL-
10/IFN-γ ratio was observed in these cultures, suggesting
the induction of a regulatory T-cell profile. In this sense,
new subsets of regulatory T cells have emerged, defined
by the expression of the HLA-G cell surface; CD4+ and
CD8+ HLA-G+ T cells. They were identified in peripheral
blood of healthy volunteers as small subsets but were able
to suppress immune responses in vitro involving IL-10 and
HLA-G as suppressive mechanisms (46–48). According to
our results, high IL-10 and low IFN-γ secretion mediated
by CD4+HLA-G+ T cells was previously reported by other
authors and, therefore, the ability of this small regulatory
T cell subset to promotion of an anti-inflammatory or
antiproliferative cytokine milieu has been suggested (46–48).
Here, we showed that Dec-CM induced the differentiation
of regulatory HLA-G+ T cells in monocytes-derived cell
cultures while Non-dec CM was unable to induce this
particular subset of regulatory CD4+ T cells, highlighting
characteristic properties of the decidualization process. It was
demonstrated that CD4+ T cells might acquire the HLA-
G molecule from decidual DCs through the trogocytosis
process (18). In fact, it was proposed that DC-10-derived
extracellular vesicles also contain soluble HLA-G (sHLA-
G) and T cells can acquire HLA-G (49). Although we
demonstrated the presence of CD4+HLA-G+ T cells on MLR
cultures performed with total lymphocytes, we observed a
low frequency of this subpopulation, suggesting that their
physiological relevance would be based on suppressive capacity
through the production of high levels of IL-10 and sHLA-
G. However, more functional studies should be performed to
address this issue.
Here we also observed an increase in the non-CD4+HLA−+
cells after the MLR cultures. In this sense, a higher frequency of
CD8+HLA-G+ T cells cells in the peripheral blood of healthy
pregnant compared to non-pregnant women, was recently
reported (50). Taking into account that there are few studies
on HLA-G+ T cell subsets in the context of pregnancy, and
are even less focused on CD8+HLA-G+, it would be interesting
to perform functional studies to characterize this unexplored
regulatory subset (6, 18, 50).
Considering the present results, we suggest that decidual
regulatory HLA-G+ T cells could be induced locally by DC-
10 which were previously differentiated in the pre-implantation
period by soluble factors released by decidualized cells. However,
we cannot exclude that the HLA-G+ T cells could also be
recruited toward the decidua from the periphery. Finally, even
though we demonstrated that, through soluble factors, the
decidualized cells induce DC-10 and condition the T cell profile
toward a tolerogenic one by the induction of regulatory T cells, it
still remains to be defined whether these mechanisms operate in
the human decidua in vivo and how they cooperate in promoting
and maintaining feto-maternal tolerance.
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